Clinical Trials Browser

Has results × Denosumab × 90 days × Clear all

NCT03620019 2026-03-27

Denosumab + PD-1 in Subjects With Stage III/ IV Melanoma

Phase 2 Completed

25 enrolled 16 charts

Melanoma

NCT03839459 2026-01-28

Denosumab for Smoldering Multiple Myeloma

Phase 2 Completed

20 enrolled 8 charts

Smoldering Multiple Myeloma